ARCH Venture Partners

Investor type

VC

Founded

1986

AUM

$9 000 M

Location

Chicago, Illinois, United States

Investment Ticket

$10-50 m

Investment Stage

Series A Seed Series B

Region of investment

North America Europe Africa Asia
Investor profile last updated: 22 August, 2026

Profile

ARCH Venture Partners is a venture capital firm based in Chicago, Illinois, founded in 1986. The firm is known for its focus on life sciences and deep-science platforms, often co-founding companies with leading scientists and entrepreneurs. ARCH has a team of 47 professionals, including 11 partners, and is recognized for its deep involvement in the commercialization of technologies developed at academic research institutions.

ARCH invests primarily in the life sciences sector, with a focus on biotechnology, health, AI, and medtech. The firm typically invests in Seed and Series A stages, with check sizes ranging from $500K to $5M. ARCH has raised multiple venture funds, including ARCH Venture Fund X and XI, with a total AUM exceeding $3 billion. The firm primarily invests in the United States but has a global reach through its extensive network.

Notable investments by ARCH Venture Partners include Illumina - genomics, Alnylam - RNAi therapeutics, Juno Therapeutics - cancer immunotherapy, Agios Pharmaceuticals - cellular metabolism, and Denali Therapeutics - neurodegenerative diseases. These companies highlight ARCH's commitment to advancing groundbreaking scientific discoveries.

Industry

Biotechnology Pharmaceuticals Education Edtech Financial Services Fintech Food and Beverage Foodtech Healthcare Services Marketing and Advertising Media and Entertainment Other Robotics Security Software Sports/SportsTech Telecommunications Transportation MedTech Life Sciences Energy HealthTech AdTech SaaS CleanTech

ARCH Venture Partners Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
ARCH Venture Fund X
Venture Capital (VC)
Healthcare Services
Media and Entertainment
SaaS
Software
Energy
HealthTech
Pre-seed
Seed
North America
$5-10 m
$1500 M
April 2020
Arch Venture Fund XI
Venture Capital (VC)
Food and Beverage
Foodtech
Healthcare Services
Media and Entertainment
SaaS
Software
Energy
CleanTech
HealthTech
Pre-seed
Seed
North America
$5-10 m
$1900 M
January 2021
ARCH Venture Fund XIII, L.P.
Venture Capital (VC)
Food and Beverage
Foodtech
Healthcare Services
Energy
CleanTech
HealthTech
Pre-seed
Seed
North America
$5-10 m
$3000 M
September 2024

Contacts

Name
Title
Email
avatar
Tom Brennan Venture Partner
Venture Partner
t•••@•••
avatar
Steve Gillis Managing Director
Managing Director
s•••@•••
Upgrade to see contacts
avatar
2fHKlJOep41dR7PY 2fHKlJOep41dR7PY
2fHKlJOep41dR7PY
avatar
2fHKlJOep41dR7PY 2fHKlJOep41dR7PY
2fHKlJOep41dR7PY
avatar
2fHKlJOep41dR7PY 2fHKlJOep41dR7PY
2fHKlJOep41dR7PY
Investment-team contacts for ARCH Venture Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about ARCH Venture Partners

ARCH Venture Partners is a venture capital firm. It backs companies at Series A, Seed and Series B, writing tickets of $10-50 m.
ARCH Venture Partners is located in Chicago, Illinois, United States.
ARCH Venture Partners was founded in 1986.
ARCH Venture Partners invests in companies and startups in Biotechnology, Pharmaceuticals, Education, Edtech, Financial Services, Fintech, Food and Beverage, Foodtech, Healthcare Services, Marketing and Advertising, Media and Entertainment, Other, Robotics, Security, Software, Sports/SportsTech, Telecommunications, Transportation, MedTech, Life Sciences, Energy, HealthTech, AdTech, SaaS, CleanTech.
ARCH Venture Partners invests in companies and startups in North America, Europe, Africa, Asia.
ARCH Venture Partners invests in companies and startups at Series A, Seed, Series B.
ARCH Venture Partners usually invests $10-50 m on average.
ARCH Venture Partners has around $9 000m assets under management.
ARCH Venture Partners last fund was created/launched in 2024-09-26
ARCH Venture Partners can be reached through its website archventure.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for ARCH Venture Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query ARCH Venture Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 22 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.